Added to YB: 2020-09-08
Pitch date: 2020-09-08
AKTX [bullish]
Akari Therapeutics, Plc
-98.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins.
Market Cap
$18.9M
Pitch Price
$31.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.42
P/E
-0.93
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
AKARI THERAPEUTICS PLC -ADR AKTX
A summary for this pitch has not been created yet.
Read full article (0 min)